Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Intimation to BSE-July 31,2017
July 31, 2017
Intimation to NSE-July 31,2017
July 31, 2017
IEPF NOTICE - BSE
July 14, 2017
IEPF NOTICE - NSE
July 14, 2017
Loss of Share Certificate - BSE
July 14, 2017
Loss of Share Certificate - NSE
July 14, 2017
Revised financial results as per Schedule III of the Companies Act,2013
July 13, 2017
Disclosure under Regulation 30 – Change in statutory auditors - NSE
June 30, 2017
CG report-quarter ended –June30,2017-BSE
June 30, 2017
CG report-quarter ended –June30,2017-NSE
June 30, 2017
Reconciliation of share capital audit-quarter ended June 30,2017-BSE
June 30, 2017
Reconciliation of share capital audit-quarter ended June 30,2017-NSE
June 30, 2017
Statement of investor complaints –quarter ended June 30,2017-BSE
June 30, 2017
Statement of investor complaints –quarter ended June 30,2017-NSE
June 30, 2017
Intimation regarding Loss of Share Certificate – BSE
June 22, 2017
Intimation regarding Loss of Share Certificate - NSE
June 22, 2017
Previous
1
...
Next
34 / 36